In Vivo Platelet Kinetics in 31 Diabetic Patients

Summary

In vivo platelet survival was estimated, in 31 diabetic patients, using ⁵¹Cr-labelled autologous platelets. A mathematical analysis attempted to measure the “potential” life span (senescence process) and the degree of a superimposed aleatory destruction (consumption process).

The potential platelet life span in diabetics did not differ from normal values. However, excessive consumption was observed in one third of the studied cases, without correlation with the age of the patients, the clinical duration of diabetes, and the degree of vascular impairment. Thus, platelet kinetic studies did not provide presently useful indications, in a particular patient, regarding the prognosis of the vascular disease, and the justification of anti-aggregant therapy.

• References

• 1 Abrahamsen AF. 1968; Platelet survival in man, with special reference to thrombosis and atherosclerosis. Scandinavian Journal of Haematology Suppl (Suppl. 03) 1
• 2 Ardaillou N. 1969 Mesure de la durée de vie des plapuettes. In: Najean Y, Ardaillou N, Dresch C. (ed.) Utilisation des techniques isotopiques en hématologie
• 3 Bloodworth JM B, Molitor DL. 1965; Ultra-structural aspects of human and canine diabetic retinopathy. Investigations of Ophthalmology 4: 1037
• 4 Dobbie JG, Kwaan HC, Colwell JA. 1973; The role of platelets pathogenesis of diabetic retinopathy. Transactions of the American Academy of Ophthalmology and Otolaryngology 77: 43
• 5 Dornhorst AC. 1961; The interpretation of red cell survival curves. Blood 6: 1284
• 6 Ferguson JC, Mackay N, Philip JA D, Sumner DJ. 1975; Determination of platelet and fibrinogen half life with 75 se selenomethionin nine: studies in normal and in diabetic subjects. Clinical Science and Molecular. Medicine 49: 115
• 7 Harher LA, Slichter SJ. 1972. Platelet and fibrinogen consumption in man. New England: Journal of Medicine. 287 999
• 8 Harker LA, Slichter SJ. 1974; Arterial and venous thromboembolism: kinetic characterization and evaluation of therapy. Thrombosis et Diathesis Haemorrhagica 31: 188
• 9 Heath H, Bridges WD, Canever JV. 1971; Platelet adhesiveness and aggregation in relation to diabetic retinopathy. Diabetologia 7: 308
• 10 I.C.S.H.: Recommended methods for platelet labelling and survival study. British Journal of Haematology. in press
• 11 Kotilainen M. 1971 Linear and exponential components of platelet turnover: a computer analysis. In: Paulus JM. (ed.) Platelet Kinetics
• 12 Kum J, Weinfeld A. 1971; Platelet survival in man. Scandinavian Journal of Haematology 8: 336
• 13 Kwaan HC, Colwell JA, Cruz S, Suwanwela N, Dobbie SG. 1972; Increased platelet aggregation in diabetes mellitus. Journal of Laboratory and Clinical Medicine 80: 236
• 14 Mills JN. 1946; The life span of the erythrocytes. Journal of Physiology 105: 16
• 15 Mustard JF, Rowsell HC, Murphy EA. 1966; Platelet economy (platelet survival and turnover). British Journal of Haematology 12: 1
• 16 Najean Y, Ardaillou N, Dresch C. 1969; Platelet life span. Annual Review of Medicine 20: 47
• 17 Najean Y. 1975 Cinétique plaquettaire. In: Meyniel. (ed.) Traité de Médecine Nucleaire
• 18 Passa Ph, Bensoussan D, Levy-Toledano S, Caen J, Canivet J. 1974; Etude de l’agrégation plaquettaire au cours de la rétinopathie diabétique. Atherosclerosis 19: 277
• 19 Paulus JM. 1971 Measuring mean life span, mean age and variance of longevity in platelets. In: Paulus JM. (ed.) Platelet kinetics
• 20 Regnault F. 1972; Rôle des plaquettes dans la pathogénie de la rétinopathie diabétique. Semaine des hôpitaux de Paris 48: 893
• 21 Sagel J, Colwell JA, Crook L. 1975; Increased platelet aggregation in early diabetes mellitus. Annals of Internal medicine 82: 733
• 22 Steele PP, Weily HS, Genton E. 1973; Platelet survival and adhesiveness in recurrent venous thrombosis. New England Journal of Medicine 288: 1148
• 23 Sullivan JM, Harker LA, Gorlin R. 1971; Pharmacologic control of thrombo-embolic complications of cardiac valve replacement. New England Journal of Medicine 284: 1391